These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 467513)

  • 1. Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN).
    Kohli JD; Goldberg LI; Nichols DE
    Eur J Pharmacol; 1979 Jun; 56(1-2):39-44. PubMed ID: 467513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational requirements for dopamine-induced vasodilation.
    Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
    Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
    Crumly HJ; Pinder RM; Hinshaw WB; Goldberg LI
    Nature; 1976 Feb; 259(5544):584-7. PubMed ID: 1250405
    [No Abstract]   [Full Text] [Related]  

  • 8. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
    Listinsky JJ; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
    Lass NA; Glock D; Goldberg LI
    Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 1. Cardiac and pressor/depressor activities.
    Gorczynski RJ; Anderson WG; Stout DM
    J Med Chem; 1981 Jul; 24(7):835-9. PubMed ID: 7277389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure--activity relationships of n-substituted dopamine and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene analogues: behavioral effects in lesioned and reserpinized mice.
    Ginos JZ; Stevens JM; Nichols DE
    J Med Chem; 1979 Nov; 22(11):1323-9. PubMed ID: 574901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the cardiac stimulant properties of (3,4-dihydroxyphenyl)-cyclopropylamine (ASL-7003) and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (A6,7DTN).
    Gorczynski RJ; Anderson WG; Erhardt PW; Stout DM
    J Pharmacol Exp Ther; 1979 Aug; 210(2):252-8. PubMed ID: 222894
    [No Abstract]   [Full Text] [Related]  

  • 14. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor.
    Nichols DE; Jacob JN; Hoffman AJ; Kohli JD; Glock D
    J Med Chem; 1984 Dec; 27(12):1701-5. PubMed ID: 6502600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
    Kohli JD; Weder AB; Goldberg LI; Ginos JZ
    J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99). I. Cardiovascular activity in the dog and cat.
    Kitzen JM; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1978 Aug; 206(2):239-47. PubMed ID: 28414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
    Seymour AA; Blaine EH
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of dopamine, NN-dialkylated dopamines and derivatives of the dopamine agonist 2-amino-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) by catechol-O-methyltransferase.
    Youde IR; Raxworthy MJ; Gulliver PA; Dijkstra D; Horn AS
    J Pharm Pharmacol; 1984 May; 36(5):309-13. PubMed ID: 6145766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M-7 lowers rabbit intraocular pressure.
    Thörig L; Hoyng PF; Timmermans PB; van Zwieten PA
    Ophthalmic Res; 1985; 17(6):362-72. PubMed ID: 4069574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE; Pendleton RG; Finlay E
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.